Profits before people? : ethical standards and the marketing of prescription drugs
The pharmaceutical industry has come under intense criticism in recent years. One poll found that 70% of the sample agreed that drug companies put profits ahead of people. Is this perception accurate? Have drug companies traded ethics for profits and placed people at risk? In Profits before People?...
Saved in:
Main Author | |
---|---|
Format | eBook Book |
Language | English |
Published |
Bloomington
Indiana University Press
2006
|
Edition | 1 |
Series | Bioethics and the Humanities |
Subjects | |
Online Access | Get full text |
ISBN | 0253347483 9780253347480 |
Cover
Loading…
Table of Contents:
- Cover Contents Acknowledgments Introduction PART ONE: THE LIMITS OF COMMERCIAL INTERESTS 1. Ethics and For-Profit Business 2. The Pharmaceutical Industry and Its Stakeholders PART TWO: MARKETING TO HEALTHCARE PROFESSIONALS 3. Drug Companies and Healthcare Professionals: The Ethics Agenda 4. Medical Professionalism and Scientific Integrity 5. The Industry’s Code: Not Good Enough 6. Drug Samples: The Most Important Gifts 7. Marketing Is Not Objective Education 8. Medical Education: Industry at Arm’s Length 9. Clinical Research and the Limits of Commercial Interests PART THREE: MARKETING TO THE PUBLIC 10. Citizens and Consumers 11. Direct-to-Consumer Advertising: Conflicting Interest 12. Direct-to-Consumer Advertising: Better Is Better Conclusion Notes Index
- Cover -- Contents -- Acknowledgments -- Introduction -- PART ONE THE LIMITS OF COMMERCIAL INTERESTS -- 1. Ethics and For-Profit Business -- 2. The Pharmaceutical Industry and ItsStakeholders -- PART TWO MARKETING TO HEALTHCARE PROFESSIONALS -- 3. Drug Companies and HealthcareProfessionals: e Ethics Agenda -- 4. Medical Professionalism and ScientificIntegrity -- 5. The Industry's Code: Not Good Enough -- 6. Drug Samples: e Most ImportantGifts -- 7. Marketing Is Not Objective Education -- 8. Medical Education: Industry at Arm'sLength -- 9. Clinical Research and the Limits ofCommercial Interests -- PART THREE MARKETING TO THE PUBLIC -- 10. Citizens and Consumers -- 11. Direct-to-Consumer Advertising:Conflicting Interest -- 12. Direct-to-Consumer Advertising:Better Is Better -- Conclusion -- Notes -- Index